Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Amedica Corporation

Market Cap 9.16M 7.91M 7.29M 6.82M 12.78M 870M 12.98M 86.05M 33.55M 424M 34.37M 33.63M 1.47B P/E Ratio 2026 *
-0.99x
P/E Ratio 2027 * -1.48x
Enterprise Value 9.16M 7.91M 7.29M 6.82M 12.78M 870M 12.98M 86.05M 33.55M 424M 34.37M 33.63M 1.47B EV / Sales 2026 *
3.98x
EV / Sales 2027 * 1.74x
Free-Float
76.57%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 2007-11-30
President - 2026-03-15
Director of Finance/CFO 41 2025-09-03
Director TitleAgeSince
Director/Board Member 63 2007-11-30
Director/Board Member 63 2025-04-02
Director/Board Member 72 2012-11-04
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 9.16M
+2.15%+2.14%-17.95%+11.53% 120B
-0.31%-1.22%+2.12%-4.39% 12.9B
+2.05%+1.45%+29.93%+89.47% 7.44B
+1.87%-4.66%-48.17%-69.38% 4.2B
+2.06%+4.10%+12.25%+35.92% 2.55B
+5.46%+10.04%-16.99%-13.15% 1.8B
+1.67%-5.73%+2.23%-10.20% 1.66B
-8.89%-10.79%+152.55%+124.20% 1.37B
Average -0.21%+0.88%+14.50%+20.50% 18.95B
Weighted average by Cap. +1.86%+1.76%-12.45%+12.66%

Financials

2026 *2027 *
Net sales 2.3M 1.99M 1.83M 1.72M 3.22M 219M 3.27M 21.65M 8.44M 107M 8.65M 8.46M 369M 5.27M 4.55M 4.19M 3.92M 7.35M 501M 7.47M 49.5M 19.3M 244M 19.77M 19.35M 844M
Net income -12.38M -10.69M -9.85M -9.22M -17.28M -1.18B -17.55M -116M -45.36M -573M -46.46M -45.47M -1.98B -11.38M -9.83M -9.05M -8.48M -15.88M -1.08B -16.13M -107M -41.69M -526M -42.7M -41.79M -1.82B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!